Activity of the heat shock protein 90 inhibitor ganetespib in melanoma.
Heat shock protein 90 (HSP90) is involved in the regulation of diverse biological processes such as cell signaling, proliferation and survival, and has been recently recognized as a potential target for cancer therapy. Ganetespib is a potent ATP competitive inhibitor of HSP90. Ganetespib downregulat...
Main Authors: | Xinqi Wu, Melina E Marmarelis, F Stephen Hodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3572008?pdf=render |
Similar Items
-
The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
by: Roberto Gomez-Casal, et al.
Published: (2015-05-01) -
Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
by: Rui Yuan, et al.
Published: (2021-05-01) -
Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling.
by: David A Proia, et al.
Published: (2011-01-01) -
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
by: Xinqi Wu, et al.
Published: (2012-01-01) -
Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
by: Min Ye, et al.
Published: (2021-07-01)